CI Cigna
Health Care · S&P 500
Next earnings: not announced yet
What 21 analyst firms say about Cigna: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
21 rated views · 23 analyst/firm records · 21 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8052
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8057
Recent analyst activity · last 90 days
Our tracked history has 10 reports on CI from 8 analyst firms in the last 90 days (22 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 4 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: SVB Leerink raised its target from $297.00 (set 6 Feb 2026) to $300.00 on 17 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Michael Ha | ConflictConflicting reports · excluded | 31 Jul 2026 | 362.00 USD |
| Barclays | Andrew Mok | Hold | 1 Oct 2026 | 310.00 USD |
| Bernstein | Lance Wilkes | Buy | 2 Oct 2026 | Conflicting reports · excluded |
| Deutsche Bank | George Hill | Hold | 20 May 2026 | 302.00 USD |
| Evercore ISI | Unnamed analyst | Hold | 9 Sep 2026 | 290.00 USD |
| Goldman Sachs | Scott Fidel | Buy | 3 Aug 2026 | 352.00 USD |
| Guggenheim | Jason Cassorla | Buy | 31 Jul 2026 | 361.00 USD |
| Jefferies | David Windley | Hold | 4 Aug 2026 | Conflicting reports · excluded |
| Leerink Partners | Whit Mayo | Hold | 17 Sep 2026 | 300.00 USD |
| Mizuho | Ann Hynes | Buy | 8 Jun 2026 | 340.00 USD |
| Morgan Stanley | Erin Wright | Buy | 20 May 2026 | 361.00 USD |
| Piper Sandler | Jessica Tassan | Buy | 23 Oct 2026 | 370.00 USD · 2 Oct 2026 |
| Raymond James | Parker Snure | Buy | 3 Aug 2026 | 320.00 USD |
| Raymond James | Sarah James | Buy | 3 Aug 2026 | 320.00 USD |
| RBC Capital Markets | Ben Hendrix | Buy | 1 Oct 2026 | 337.00 USD |
| TD Cowen | Charles Rhyee | Buy | 9 Feb 2026 | 338.00 USD |
| TD Cowen | Ryan Langston | Buy | 9 Feb 2026 | 338.00 USD |
| Truist | David MacDonald | Buy | 17 Feb 2026 | 350.00 USD |
| UBS | A.J. Rice | Buy | 1 Oct 2026 | 400.00 USD |
| Weiss Ratings | Unnamed analyst | — | 27 Aug 2026 | — |
| Wells Fargo | Stephen Baxter | Hold | 31 Jul 2026 | 307.00 USD |
| Wolfe Research | Justin Lake | Buy | 16 Jun 2026 | 315.00 USD |
| Data feed RESEARCH | Research Team | Hold | 5 Jan 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:22 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.